Physician profile
Cherry H Jones
NPI 1962449595
$1,309.83
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $646 · 2022: $545 · 2023: $100 · 2024: $18.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $119.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $198.26 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $123.16 | 2021 | |
| Exeltis, USA INC. | $107.33 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $104.24 | 2021-2022 | |
| Agile Therapeutics, INC. | $83.83 | 2021-2023 | Twirla |
| Astellas Pharma US INC | $61.95 | 2022 | |
| Myovant Sciences INC. | $58.70 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.55 | 2021-2023 | |
| Organon LLC | $52.15 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $45.66 | 2021-2022 | |
| Coopersurgical, INC. | $44.47 | 2021 | |
| Aspira Women'S Health INC | $42.65 | 2022 | |
| Therapeuticsmd, INC. | $41.04 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $39.26 | 2022 | |
| Hologic Sales and Service, LLC | $37.75 | 2021-2024 | Myosure Tissue Removal Device |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renovia INC | $31.60 | 2021 | |
| Pfizer INC. | $27.37 | 2022-2023 | |
| Medicem INC. | $22.31 | 2021 | |
| Sumitomo Pharma America, INC. | $19.90 | 2023 | Myfembree |
| Lupin INC. | $19.85 | 2021 | |
| Novo Nordisk INC | $17.91 | 2023 | |
| Merck Sharp & Dohme LLC | $16.71 | 2021 | |
| Avion Pharmaceuticals | $16.18 | 2021 | |
| Scynexis, INC. | $15.94 | 2022 | |
| Evofem Biosciences, INC. | $12.57 | 2021 | |
| Shield Therapeutics INC | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cherry Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.